Private Equity 24 Hours

Last updated: May 15, 2026, 11:30 AM ET

European Deal Flow & Fundraising

Private equity capital is flowing into European startups at a brisk pace, with a series of high-profile transactions signaling appetite for frontier technology and consumer platforms. Dutch dronemaker Destinus is in talks to raise €200 million, underscoring investor confidence in hypersonic aviation despite the technical hurdles. Across the Channel, CPP Investments committed €400m to co-invest with Blackstone in Proudreed, a French last-mile logistics platform, marking one of the largest minority stakes committed to a European infrastructure play this year. Meanwhile, L Catterton backed Saint Bella in a push to build a global family-care platform out of China, betting on the convergence of premium consumer branding and cross-border expansion. The fundraising momentum extends to early-stage venture capital as well: Meridian Ventures launched a $35M fund to back MBA-deferred founders, while Euan Blair's Multiverse raised $70m to expand its valuation in the employee experience software space. These capital deployments come as European startups are simultaneously hunting for acquisitions, with several firms reporting they are raising cash while on the lookout for bolt-on targets.

Pharma, Life Sciences & Niche Industry Plays

Private equity firms are homing in on the pharmaceutical and life sciences consulting sector, drawn by the complexity of drug R&D pipelines and the recurring revenue characteristics of advisory platforms. Blackstone, Audax, Five Arrows and others are eyeing pharmaceutical and life science consulting firms, with Eir Partners making a direct bet by investing in QuartzBio, a life sciences data analytics company. The appetite is broadening: PE seeks pharmaceutical and life sciences consulting firms across 7 deals, with Blackstone, Audax, Bridgepoint and Baird all targeting add-on platforms. The same revenue predictability thesis is pulling capital into the testing, inspection and certification industry, where Ardian, Blackstone, Bridgepoint and EQT are among firms backing TICC targets. On the buyout side, Fusion Capital-backed Relevant acquired Automation Werx, a systems integration firm in Houston, while HIG Capital snapped up International Aerospace Coatings, which serves major airlines and MRO providers. In another corner of the market, Balance Point injected capital into The Edge, a jewelry retail software provider tied to Serent Capital's acquisition, and General Atlantic invested in PowerGEM, which had been backed by TA Associates since 2024.

Blackstone's Active Deal Calendar

Blackstone's transaction pace shows no signs of slowing. The firm is weighing take-private bids for Magnum Ice Cream alongside CD&R, with the listed ice cream giant trading below its IPO price and presenting a classic going-private opportunity. In healthcare, Blackstone and KKR seized control of Affordable Care through a restructuring that writes off roughly 70% of the company's debt, led by a group of direct lenders. The firm's footprint in European infrastructure also deepened with the Proudreed logistics deal, bringing CPP Investments on as a co-investor at the €400 million level. Across the Atlantic, the firm is also among those pushing into pharmaceutical consulting and life sciences data analytics, reinforcing a diversification strategy that spans consumer staples, healthcare and industrial services.

Tech IPOs, AI and Market Headwinds

The public markets are rewarding hardware and AI bets, even as the broader tech sector grapples with layoffs. Cerebras IPO made billions for Benchmark after the AI chip startup's long-awaited Nasdaq debut, with shares surging on the first day of trading after years of private fundraising and scrapped IPO plans. The exit was years in the making — Benchmark almost never backs hardware startups and partner Eric Vishria nearly passed on the initial meeting. The backdrop for such outsized IPO returns is a tech labor market still contracting: over 127,000 workers at U.S.-based tech companies were laid off in 2025, with job cuts continuing into 2026. On the startup front, an 11-person London startup is targeting 100x cheaper AI, while Meridian Ventures' new fund backs MBA-deferred founders who are building pre-seed companies. Elsewhere in the ecosystem, James Wise defended the Sovereign AI Unit thesis, arguing that criticism of the investment model is misplaced, though he conceded one company he wished he had backed.

Conferences, Secondaries & LP Relations

The global private equity calendar is filling up with major events: Italy's largest PE conference returns to Milan next May, France's to Paris next March, the Nordics' to Stockholm this November, and Iberia's to Madrid this October. On the secondaries front, Lazard's acquisition of Campbell Lutyens proves scale matters, with industry observers cautioning that success in the space will come with a premium price tag. LP relationships remain a priority, with dealers urged not to skip AGMs since active participation is part of the fiduciary relationship. The broader case for patience in private markets is gaining traction as companies stay private longer and retail allocations to PE grow, while TICC's embrace of AI is helping attract PE capital according to Houlihan Lokey, reflecting how even traditional sectors are being repositioned by technology adoption.